SARS-CoV-2 seroprevalence during the 1st and 2nd pandemic waves in Canada

In their CITF-funded research, in preprint and not yet peer reviewed, Dr. Prabhat Jha and his team leading the Action to Beat Coronavirus (Ab-C) study estimated cumulative seroprevalence of SARS-CoV-2 through infection among unvaccinated adults rose from about 2% after the first wave to 7% after the second. The numbers were based on blood … Continue reading SARS-CoV-2 seroprevalence during the 1st and 2nd pandemic waves in Canada